Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
NPJ Breast Cancer|February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancerClara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.Breast Cancer Research : BCR|November 16, 2019
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trialWilliam Jacot, Paul Cottu, Frederique Berger, et al.Breast Cancer Research : BCR|March 13, 2025
Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysisDiana Zhang, Shayesteh Jahanfar, Judy B Rabinowitz, et al.Plos One|October 12, 2012
Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classificationFabien Reyal, Catherine Belichard, Roman Rouzier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2017
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their MetastasesCharlotte K Y Ng, Francois-Clement Bidard, Salvatore Piscuoglio, et al.NPJ Breast Cancer|April 27, 2026
Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trialJoyce O'Shaughnessy, Francois-Clement Bidard, Patrick Neven, et al.Angiogenesis|November 28, 2019
Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)Antoine Vasseur, Luc Cabel, Olivier Tredan, et al.International Journal of Cancer|October 14, 2014
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patientsJordan Madic, Anna Kiialainen, Francois-Clement Bidard, et al.European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumorsEleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.Breast Cancer Research : BCR|January 20, 2021
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre studyMarion Alhenc-Gelas, Luc Cabel, Frederique Berger, et al.Pageof 5